MicroRNA in Human Acute Kidney Injury: A Systematic Review Protocol

Adrianna Douvris1, Dylan Burger1,2, Rosendo A Rodriguez3

  • 1Division of Nephrology, Department of Medicine and Kidney Research Centre, Ottawa Hospital Research Institute, The University of Ottawa and The Ottawa Hospital, ON, Canada.

Abstract

Insights

This systematic review evaluates microRNAs (miRNAs) in human acute kidney injury (AKI). It identifies promising miRNAs and research constraints to guide future studies on AKI prevention and treatment.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Nephrology

Background:

  • Acute kidney injury (AKI) is a significant cause of hospitalization with high mortality and limited treatment options.
  • Current diagnostic tools for AKI have limitations in early identification.
  • MicroRNAs (miRNAs) are implicated in AKI pathogenesis, with potential therapeutic roles shown in animal models, but their role in human AKI is less understood.

Purpose of the Study:

  • To systematically review and analyze the role of microRNAs (miRNAs) in human subjects diagnosed with acute kidney injury (AKI).
  • To identify specific miRNAs that show promise for research in human AKI.
  • To highlight methodological limitations in current miRNA research concerning human AKI.

Main Methods:

  • A systematic review and meta-analysis approach was employed.
  • A comprehensive literature search was conducted across multiple databases (Ovid MEDLINE All, Embase, Web of Science, CENTRAL).
  • Studies quantifying miRNA levels in human samples (blood, urine, kidney biopsy) and measuring renal function were included; study quality and heterogeneity were assessed.

Main Results:

  • The review will characterize promising miRNAs for human AKI research.
  • Methodological constraints in current miRNA research for human AKI will be identified.
  • The potential for meta-analysis will be assessed based on study heterogeneity.

Conclusions:

  • There is a lack of randomized trials investigating miRNAs for human AKI prevention or treatment.
  • The quality of included studies and sources of heterogeneity pose challenges to the strength and reproducibility of findings.
  • This review aims to inform future research design by identifying key miRNAs and methodological constraints in human AKI miRNA studies.

Related Concept Videos

Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
229
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
465
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
110
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
375
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
100
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
160